Abstract
Medial prefrontal cortex (mPFC) activity is necessary for the rapid antidepressant effects of ketamine. The mPFC is comprised of multiple pyramidal neuron subtypes but their individual role in the antidepressant response in unclear. The current study addresses this issue using transgenic mice that express Cre recombinase under the control of the dopamine Drd1 or Drd2 promoters to target viral constructs to pyramidal neuron subtypes in an attempt to elucidate their role in rapid antidepressant responses.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
